{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T21:03:46Z","timestamp":1791147826888,"version":"4.1.0"},"reference-count":89,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100013927","name":"National MPS Society","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100013927","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["mgmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.ymgme.2013.07.016","type":"journal-article","created":{"date-parts":[[2013,7,29]],"date-time":"2013-07-29T22:16:01Z","timestamp":1375136161000},"page":"73-83","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":75,"title":["Glycan-based biomarkers for mucopolysaccharidoses"],"prefix":"10.1016","volume":"111","author":[{"given":"Roger","family":"Lawrence","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jillian R.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred","family":"Lorey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia I.","family":"Dickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett E.","family":"Crawford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey D.","family":"Esko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2013.07.016_bb0005","series-title":"Metabolic and Molecular Basis of Inherited Disease","first-page":"3371","article-title":"Lysosomal Disorders","year":"2001"},{"key":"10.1016\/j.ymgme.2013.07.016_bb0010","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1136\/adc.2009.171827","article-title":"\u2018Doctor Google\u2019 ending the diagnostic odyssey in lysosomal storage disorders: parents using internet search engines as an efficient diagnostic strategy in rare diseases","volume":"95","author":"Bouwman","year":"2010","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.ymgme.2013.07.016_bb0015","series-title":"Metabolic and Molecular Basis of Inherited Disease","first-page":"3421","article-title":"The Mucopolysaccharidoses","author":"Neufeld","year":"2001"},{"key":"10.1016\/j.ymgme.2013.07.016_bb0020","doi-asserted-by":"crossref","first-page":"34836","DOI":"10.1074\/jbc.M112.390161","article-title":"Deciphering mode of action of heparanase using structurally defined oligosaccharides","volume":"287","author":"Peterson","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2013.07.016_bb0025","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1093\/glycob\/cwp174","article-title":"Identification of human hyaluronidase-4 as a novel chondroitin sulfate hydrolase that preferentially cleaves the galactosaminidic linkage in the trisulfated tetrasaccharide sequence","volume":"20","author":"Kaneiwa","year":"2010","journal-title":"Glycobiology"},{"key":"10.1016\/j.ymgme.2013.07.016_bb0030","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1590\/S1415-47572010005000093","article-title":"Mucopolysaccharidosis I, II, and VI: Brief review and guidelines for treatment","volume":"33","author":"Giugliani","year":"2010","journal-title":"Genet. Mol. Biol."},{"key":"10.1016\/j.ymgme.2013.07.016_bb0035","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.expneurol.2010.07.024","article-title":"Allogeneic stem cell transplantation does not improve neurological deficits in mucopolysaccharidosis type IIIA mice","volume":"225","author":"Lau","year":"2010","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ymgme.2013.07.016_bb0040","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/sj.bmt.1705569","article-title":"Biochemical monitoring after haemopoietic stem cell transplant for Hurler syndrome (MPSIH): implications for functional outcome after transplant in metabolic disease","volume":"39","author":"Church","year":"2007","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.ymgme.2013.07.016_bb0045","doi-asserted-by":"crossref","first-page":"884","DOI":"10.2174\/138920111795542679","article-title":"Cell- and gene-based therapeutic approaches for neurological deficits in mucopolysaccharidoses","volume":"12","author":"Pan","year":"2011","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.ymgme.2013.07.016_bb0050","doi-asserted-by":"crossref","first-page":"923","DOI":"10.2174\/138920111795542651","article-title":"Mucopolysaccharidosis Type III (Sanfilippo syndrome): emerging treatment strategies","volume":"12","author":"de Ruijter","year":"2011","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.ymgme.2013.07.016_bb0055","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.2174\/138920111798376932","article-title":"Substrate reduction therapies for mucopolysaccharidoses","volume":"12","author":"Jakobkiewicz-Banecka","year":"2011","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.ymgme.2013.07.016_bb0060","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/rheumatology\/ker396","article-title":"Therapy for the mucopolysaccharidoses","volume":"50","author":"Valayannopoulos","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ymgme.2013.07.016_bb0065","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/rheumatology\/ker394","article-title":"Overview of the mucopolysaccharidoses","volume":"50","author":"Muenzer","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ymgme.2013.07.016_bb0070","series-title":"Fabry Disease: Perspectives from 5 Years of FOS","article-title":"Enzyme replacement therapy - a brief history","author":"Neufeld","year":"2006"},{"key":"10.1016\/j.ymgme.2013.07.016_bb0075","first-page":"124","article-title":"Novel treatments and future perspectives: outcomes of intrathecal drug delivery","volume":"47","author":"Dickson","year":"2009","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ymgme.2013.07.016_bb0080","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ymgme.2006.12.012","article-title":"Intrathecal enzyme replacement therapy: successful treatment of brain disease via the cerebrospinal fluid","volume":"91","author":"Dickson","year":"2007","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2013.07.016_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00063030-200519010-00001","article-title":"Laronidase treatment of mucopolysaccharidosis I","volume":"19","author":"Wraith","year":"2005","journal-title":"BioDrugs"},{"key":"10.1016\/j.ymgme.2013.07.016_bb0090","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nchembio.766","article-title":"Disease-specific non-reducing end carbohydrate biomarkers for mucopolysaccharidoses","volume":"8","author":"Lawrence","year":"2012","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ymgme.2013.07.016_bb0095","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s10545-010-9078-6","article-title":"Lessons learnt from animal models: pathophysiology of neuropathic lysosomal storage disorders","volume":"33","author":"Hemsley","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2013.07.016_bb0100","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s10545-011-9308-6","article-title":"Biomarkers in the diagnosis of lysosomal storage disorders: proteins, lipids, and inhibodies","volume":"34","author":"Aerts","year":"2011","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2013.07.016_bb0105","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/rheumatology\/ker390","article-title":"Diagnosis of the mucopolysaccharidoses","volume":"50","author":"Lehman","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ymgme.2013.07.016_bb0110","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.ymgme.2012.05.003","article-title":"Biomarkers for the mucopolysaccharidoses: Discovery and clinical utility","volume":"106","author":"Clarke","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2013.07.016_bb0115","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.bbagen.2011.12.001","article-title":"Glycans as cancer biomarkers","volume":"1820","author":"Adamczyk","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymgme.2013.07.016_bb0120","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/nrc1649","article-title":"The sweet and sour of cancer: glycans as novel therapeutic targets","volume":"5","author":"Fuster","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ymgme.2013.07.016_bb0125","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1002\/ana.22092","article-title":"Mucopolysaccharidosis type IIIA: clinical spectrum and genotype-phenotype correlations","volume":"68","author":"Valstar","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ymgme.2013.07.016_bb0130","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1093\/clinchem\/35.3.374","article-title":"Diagnostic test for mucopolysaccharidosis I. Direct method for quantifying excessive urinary glycosaminoglycan excretion","volume":"35","author":"Whitley","year":"1989","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ymgme.2013.07.016_bb0135","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1093\/clinchem\/35.7.1472","article-title":"Dimethylmethylene blue-based spectrophotometry of glycosaminoglycans in untreated urine: a rapid screening procedure for mucopolysaccharidoses","volume":"35","author":"de Jong","year":"1989","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ymgme.2013.07.016_bb0140","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1542\/peds.2007-3847","article-title":"Long-term efficacy and safety of laronidase in the treatment of mucopolysaccharidosis I","volume":"123","author":"Clarke","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgme.2013.07.016_bb0145","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/01.gim.0000232477.37660.fb","article-title":"A phase II\/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome)","volume":"8","author":"Muenzer","year":"2006","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgme.2013.07.016_bb0150","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.jpeds.2005.12.014","volume":"148","author":"Harmatz","year":"2006","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2013.07.016_bb0155","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1021\/jf072624v","article-title":"Characterization and purification of glycosaminoglycans from crude biological samples","volume":"56","author":"Davies","year":"2008","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.ymgme.2013.07.016_bb0160","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/jcla.10051","article-title":"MPS screening methods, the Berry spot and acid turbidity tests, cause a high incidence of false-negative results in Sanfilippo and Morquio syndromes","volume":"16","author":"Chih-Kuang","year":"2002","journal-title":"J. Clin. Lab. Anal."},{"key":"10.1016\/j.ymgme.2013.07.016_bb0165","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1177\/000456329403100309","article-title":"Mucopolysaccharidoses screening: dimethylmethylene blue versus alcian blue","volume":"31","author":"de Jong","year":"1994","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.ymgme.2013.07.016_bb0170","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.cccn.2004.03.015","article-title":"Evaluation of reliability for urine mucopolysaccharidosis screening by dimethylmethylene blue and Berry spot tests","volume":"345","author":"Mabe","year":"2004","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ymgme.2013.07.016_bb0175","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/jcla.20453","article-title":"Reliability of a visual test for the rapid detection of mucopolysaccharidoses: GAG-test((R))","volume":"25","author":"Lage","year":"2011","journal-title":"J. Clin. Lab. Anal."},{"key":"10.1016\/j.ymgme.2013.07.016_bb0180","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s10545-005-0069-y","article-title":"Heparan sulfate levels in mucopolysaccharidoses and mucolipidoses","volume":"28","author":"Tomatsu","year":"2005","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2013.07.016_bb0185","doi-asserted-by":"crossref","first-page":"69","DOI":"10.4137\/BMI.S7451","article-title":"Comparison of liquid chromatography\u2013tandem mass spectrometry and sandwich ELISA for determination of keratan sulfate in plasma and urine","volume":"6","author":"Hintze","year":"2011","journal-title":"Biomark. Insights"},{"key":"10.1016\/j.ymgme.2013.07.016_bb0190","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.cellbi.2009.04.018","article-title":"Quantitative determination and comparison of the glycosaminoglycan Delta-disaccharide composition in 22 different human cell lines","volume":"33","author":"Ambrosius","year":"2009","journal-title":"Cell Biol. Int."},{"key":"10.1016\/j.ymgme.2013.07.016_bb0195","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ab.2007.05.016","article-title":"Analytical method for the determination of disaccharides derived from keratan, heparan, and dermatan sulfates in human serum and plasma by high-performance liquid chromatography\/turbo ion spray ionization tandem mass spectrometry","volume":"368","author":"Oguma","year":"2007","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ymgme.2013.07.016_bb0200","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ymgme.2009.10.001","article-title":"Validation of disaccharide compositions derived from dermatan sulfate and heparan sulfate in mucopolysaccharidoses and mucolipidoses II and III by tandem mass spectrometry","volume":"99","author":"Tomatsu","year":"2010","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2013.07.016_bb0205","doi-asserted-by":"crossref","first-page":"3703","DOI":"10.1021\/ac2001077","article-title":"A comprehensive compositional analysis of heparin\/heparan sulfate-derived disaccharides from human serum","volume":"83","author":"Wei","year":"2011","journal-title":"Anal. Chem."},{"key":"10.1016\/j.ymgme.2013.07.016_bb0210","doi-asserted-by":"crossref","first-page":"37515","DOI":"10.1074\/jbc.M111.287474","article-title":"Mucopolysaccharidosis type I: Unique structure of accumulated heparan sulfate and increased N-sulfotransferase activity in mice lacking alpha-L-iduronidase","volume":"286","author":"Holley","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2013.07.016_bb0215","doi-asserted-by":"crossref","first-page":"23898","DOI":"10.1016\/S0021-9258(20)80470-0","article-title":"Minimal sequence in heparin\/heparan sulfate required for binding of basic fibroblast growth factor","volume":"268","author":"Maccarana","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2013.07.016_bb0220","doi-asserted-by":"crossref","first-page":"17711","DOI":"10.1074\/jbc.271.30.17711","article-title":"An animal cell mutant defective in heparan sulfate hexuronic acid 2-O-sulfation","volume":"271","author":"Bai","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2013.07.016_bb0225","doi-asserted-by":"crossref","first-page":"e10691","DOI":"10.1371\/journal.pone.0010691","article-title":"Loss of the heparan sulfate sulfotransferase, Ndst1, in mammary epithelial cells selectively blocks lobuloalveolar development in mice","volume":"5","author":"Crawford","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.ymgme.2013.07.016_bb0230","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1172\/JCI115093","article-title":"High-affinity binding of interferon-gamma to a basement membrane complex (matrigel)","volume":"87","author":"Lortat-Jacob","year":"1991","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymgme.2013.07.016_bb0235","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1093\/glycob\/8.10.1029","article-title":"Differentiation-associated modulation of heparan sulfate structure and function in CaCo-2 colon carcinoma cells","volume":"8","author":"Salmivirta","year":"1998","journal-title":"Glycobiology"},{"key":"10.1016\/j.ymgme.2013.07.016_bb0240","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1093\/glycob\/3.3.271","article-title":"Mode of interaction between platelet factor 4 and heparin","volume":"3","author":"Maccarana","year":"1993","journal-title":"Glycobiology"},{"key":"10.1016\/j.ymgme.2013.07.016_bb0245","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ymgme.2006.01.005","article-title":"Heparin cofactor II-thrombin complex in MPS I: a biomarker of MPS disease","volume":"88","author":"Randall","year":"2006","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2013.07.016_bb0250","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1093\/glycob\/cwj117","article-title":"N-Acetylgalactosamine 4,6-O-sulfate residues mediate binding and activation of heparin cofactor II by porcine mucosal dermatan sulfate","volume":"16","author":"Halldorsdottir","year":"2006","journal-title":"Glycobiology"},{"key":"10.1016\/j.ymgme.2013.07.016_bb0255","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1161\/01.ATV.0000256471.22437.88","article-title":"Heparin cofactor II modulates the response to vascular injury","volume":"27","author":"Tollefsen","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ymgme.2013.07.016_bb0260","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s10545-010-9254-8","article-title":"Heparin cofactor II-thrombin complex and dermatan sulphate:chondroitin sulphate ratio are biomarkers of short- and long-term treatment effects in mucopolysaccharide diseases","volume":"34","author":"Langford-Smith","year":"2011","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2013.07.016_bb0265","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.ymgme.2008.05.001","article-title":"Heparin cofactor II-thrombin complex: a biomarker of MPS disease","volume":"94","author":"Randall","year":"2008","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2013.07.016_bb0270","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s10545-011-9369-6","article-title":"Longitudinal observations of serum heparin cofactor II-thrombin complex in treated Mucopolysaccharidosis I and II patients","volume":"35","author":"Clarke","year":"2012","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2013.07.016_bb0275","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/S0140-6736(73)90560-6","article-title":"Prenatal diagnosis of mucopolysaccharidoses","volume":"1","author":"Whiteman","year":"1973","journal-title":"Lancet"},{"key":"10.1016\/j.ymgme.2013.07.016_bb0280","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.jpeds.2008.11.005","article-title":"Improved metabolic correction in patients with lysosomal storage disease treated with hematopoietic stem cell transplant compared with enzyme replacement therapy","volume":"154","author":"Wynn","year":"2009","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2013.07.016_bb0285","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1093\/glycob\/cwh049","article-title":"Glycosaminoglycan degradation fragments in mucopolysaccharidosis I","volume":"14","author":"Fuller","year":"2004","journal-title":"Glycobiology"},{"key":"10.1016\/j.ymgme.2013.07.016_bb0290","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ymgme.2005.09.026","article-title":"Validation of a heparan sulfate-derived disaccharide as a marker of accumulation in murine mucopolysaccharidosis type IIIA","volume":"87","author":"King","year":"2006","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2013.07.016_bb0295","first-page":"141","article-title":"N-acetylglucosamine 6-sulfate residues in keratan sulfate and heparan sulfate are desulfated by the same enzyme","volume":"6","author":"Hopwood","year":"1983","journal-title":"Biochem. Int."},{"key":"10.1016\/j.ymgme.2013.07.016_bb0300","first-page":"831","article-title":"Isolation and characterization of N-acetylglucosamine 6-sulfate from the urine of a patient with Sanfilippo type D syndrome and its occurrence in normal urine","volume":"6","author":"Hopwood","year":"1983","journal-title":"Biochem. Int."},{"key":"10.1016\/j.ymgme.2013.07.016_bb0305","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1042\/bj2290579","article-title":"Urinary excretion of sulphated N-acetylhexosamines in patients with various mucopolysaccharidoses","volume":"229","author":"Hopwood","year":"1985","journal-title":"Biochem. J."},{"key":"10.1016\/j.ymgme.2013.07.016_bb0310","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S1096-7192(03)00018-0","article-title":"Determination of monosaccharides and disaccharides in mucopolysaccharidoses patients by electrospray ionisation mass spectrometry","volume":"78","author":"Ramsay","year":"2003","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2013.07.016_bb0315","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s10545-012-9535-5","article-title":"Heparan sulfate derived disaccharides in plasma and total urinary excretion of glycosaminoglycans correlate with disease severity in Sanfilippo disease","volume":"36","author":"de Ruijter","year":"2013","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2013.07.016_bb0320","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.ymgme.2012.09.024","article-title":"Heparan sulfate and dermatan sulfate derived disaccharides are sensitive markers for newborn screening for mucopolysaccharidoses types I, II and III","volume":"107","author":"de Ruijter","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2013.07.016_bb0325","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s10545-009-9036-3","article-title":"Dermatan sulfate and heparan sulfate as a biomarker for mucopolysaccharidosis I","volume":"33","author":"Tomatsu","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2013.07.016_bb0330","doi-asserted-by":"crossref","DOI":"10.1007\/s10545-009-9013-x","article-title":"Validation of keratan sulfate level in mucopolysaccharidosis type IVA by liquid chromatography\u2013tandem mass spectrometry","author":"Tomatsu","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2013.07.016_bb0335","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ymgme.2008.01.007","article-title":"Acidic amino acid tag enhances response to enzyme replacement in mucopolysaccharidosis type VII mice","volume":"94","author":"Montano","year":"2008","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2013.07.016_bb0340","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ymgme.2013.04.002","article-title":"Review of clinical presentation and diagnosis of mucopolysaccharidosis IVA","volume":"110","author":"Hendriksz","year":"2013","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2013.07.016_bb0345","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/BF02798420","article-title":"Polysaccharide lyases","volume":"12","author":"Linhardt","year":"1986","journal-title":"Appl. Biochem. Biotechnol."},{"key":"10.1016\/j.ymgme.2013.07.016_bb0350","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1006\/mgme.1998.2761","article-title":"Glycosaminoglycan accumulation and excretion in the mucopolysaccharidoses: characterization and basis of a diagnostic test for MPS","volume":"65","author":"Byers","year":"1998","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2013.07.016_bb0355","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1093\/glycob\/9.12.1389","article-title":"A mouse model for mucopolysaccharidosis type III A (Sanfilippo syndrome)","volume":"9","author":"Bhaumik","year":"1999","journal-title":"Glycobiology"},{"key":"10.1016\/j.ymgme.2013.07.016_bb0360","doi-asserted-by":"crossref","first-page":"33674","DOI":"10.1074\/jbc.M804288200","article-title":"Evolutionary differences in glycosaminoglycan fine structure detected by quantitative glycan reductive isotope labeling","volume":"283","author":"Lawrence","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2013.07.016_bb0365","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ab.2009.01.028","article-title":"Glycan reductive isotope labeling for quantitative glycomics","volume":"387","author":"Xia","year":"2009","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ymgme.2013.07.016_bb0370","doi-asserted-by":"crossref","first-page":"18336","DOI":"10.1074\/jbc.M110.101592","article-title":"Extended N-sulfated domains reside at the nonreducing end of heparan sulfate chains","volume":"285","author":"Staples","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2013.07.016_bb0375","doi-asserted-by":"crossref","first-page":"36283","DOI":"10.1074\/jbc.M112.403360","article-title":"A genetic model of substrate reduction therapy for mucopolysaccharidosis","volume":"287","author":"Lamanna","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2013.07.016_bb0380","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1203\/01.PDR.0000113767.60140.E9","article-title":"Development and testing of new screening method for keratan sulfate in mucopolysaccharidosis IVA","volume":"55","author":"Tomatsu","year":"2004","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.ymgme.2013.07.016_bb0385","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.4155\/bio.11.172","article-title":"Validation of an LC\u2013MS\/MS assay for detecting relevant disaccharides from keratan sulfate as a biomarker for Morquio A syndrome","volume":"3","author":"Martell","year":"2011","journal-title":"Bioanalysis"},{"key":"10.1016\/j.ymgme.2013.07.016_bb0390","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s10545-005-5673-3","article-title":"Keratan sulphate levels in mucopolysaccharidoses and mucolipidoses","volume":"28","author":"Tomatsu","year":"2005","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2013.07.016_bb0395","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ymgme.2004.07.015","article-title":"Determination of oligosaccharides and glycolipids in amniotic fluid by electrospray ionisation tandem mass spectrometry: in utero indicators of lysosomal storage diseases","volume":"83","author":"Ramsay","year":"2004","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2013.07.016_bb0400","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1542\/peds.2004-0583","article-title":"Newborn screening for lysosomal storage disorders: clinical evaluation of a two-tier strategy","volume":"114","author":"Meikle","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgme.2013.07.016_bb0405","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.ymgme.2009.10.175","article-title":"Evaluation of heparin cofactor II-thrombin complex as a biomarker on blood spots from mucopolysaccharidosis I, IIIA and IIIB mice","volume":"99","author":"Langford-Smith","year":"2010","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2013.07.016_bb0410","doi-asserted-by":"crossref","first-page":"e14192","DOI":"10.1371\/journal.pone.0014192","article-title":"Genistein improves neuropathology and corrects behaviour in a mouse model of neurodegenerative metabolic disease","volume":"5","author":"Malinowska","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.ymgme.2013.07.016_bb0415","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ymgme.2012.02.003","article-title":"Specific antibody titer alters the effectiveness of intrathecal enzyme replacement therapy in canine mucopolysaccharidosis I","volume":"106","author":"Dickson","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2013.07.016_bb0420","doi-asserted-by":"crossref","first-page":"6955","DOI":"10.1074\/jbc.M110.192062","article-title":"Secondary storage of dermatan sulfate in Sanfilippo disease","volume":"286","author":"Lamanna","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2013.07.016_bb0425","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1146\/annurev.genom.6.080604.162334","article-title":"Sulfatases and human disease","volume":"6","author":"Diez-Roux","year":"2005","journal-title":"Annu. Rev. Genomics Hum. Genet."},{"key":"10.1016\/j.ymgme.2013.07.016_bb0430","doi-asserted-by":"crossref","first-page":"14775","DOI":"10.1073\/pnas.0914206107","article-title":"A canine Arylsulfatase G (ARSG) mutation leading to a sulfatase deficiency is associated with neuronal ceroid lipofuscinosis","volume":"107","author":"Abitbol","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ymgme.2013.07.016_bb0435","doi-asserted-by":"crossref","first-page":"10310","DOI":"10.1073\/pnas.1202071109","article-title":"Arylsulfatase G inactivation causes loss of heparan sulfate 3-O-sulfatase activity and mucopolysaccharidosis in mice","volume":"109","author":"Kowalewski","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ymgme.2013.07.016_bb0440","doi-asserted-by":"crossref","first-page":"5398","DOI":"10.1002\/pmic.200900708","article-title":"Symbol nomenclature for glycan representation","volume":"9","author":"Varki","year":"2009","journal-title":"Proteomics"},{"key":"10.1016\/j.ymgme.2013.07.016_bb0445","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/nmeth0408-291","article-title":"Disaccharide structure code for the easy representation of constituent oligosaccharides from glycosaminoglycans","volume":"5","author":"Lawrence","year":"2008","journal-title":"Nat. Methods"}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719213002643?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719213002643?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,2]],"date-time":"2022-03-02T13:52:29Z","timestamp":1646229149000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719213002643"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":89,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S1096719213002643"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2013.07.016","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glycan-based biomarkers for mucopolysaccharidoses","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2013.07.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}